Health Insurance - Coverage for Specialty Drugs - Rheumatologic Conditions

HB 1461 requires Maryland insurers, nonprofit health plans, and health maintenance organizations to cover specialty drugs for rheumatologic conditions (like rheumatoid arthritis) when administered or dispensed by in-network rheumatology providers meeting state regulations. It prohibits insurers from excluding coverage for these drugs based solely on the provider’s location (e.g., office-based vs. specialty pharmacy) and mandates fair reimbursement rates comparable to those paid to designated specialty pharmacies. The bill specifically applies to oral medications requiring complex dosing, auto-injected drugs, or those used with infusion therapies. It does not override medical necessity standards for coverage denial but aims to prevent treatment delays and ensure access to office-based care for patients with chronic rheumatologic conditions.